Portland, United States
Sirona Dx, founded in 2016, positions itself as a pivotal innovator in the Biotechnology sector headquartered in the United States. Known as The I-O Clinical Service Laboratory, the company differentiates itself as a technical CRO that pushes boundaries with its early adoption of leading-edge technologies.
Unlike traditional CROs, Sirona Dx acts at the intersection of tools development and biopharma, enabling clients to access cutting-edge technologies and expertise within a CLIA accredited, GCLP compliant environment. Their comprehensive services extend from platform selection to the validation of complex multi-analyte assays, leveraging breakthrough technologies for single-cell resolution and tissue spatial context.
The company has pioneered in the spatial biology field, launching the first spatial-omics CRO service with IMC technology developed by Fluidigm. Their technology-agnostic suite now includes the leading platforms, with capabilities to develop complex panels of up to 40 markers. Strategic utilization of CyTOF technology allows for ultra-deep immune profiling, strengthening their value proposition from exploratory testing to clinical trials support.
